Pliant Therapeutics, Inc. (PLRX) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Track Pliant Therapeutics, Inc. (PLRX) stock performance with short-term forecasts for 2025 and long-term PLRX price prediction till 2050. Review historical trends, get analyst Buy/Sell/Hold ratings, and stay updated with the latest Pliant Therapeutics, Inc. headlines.
1 Month Prediction
$24.39 [735.29%]
3 Month Prediction
$19.27 [559.97%]
6 Month Prediction
$19.13 [554.95%]
1 Year Prediction
$13.15 [350.26%]
3 Year Prediction
$1.00 [-65.75%]
5 Year Prediction
$1.00 [-65.75%]
About Pliant Therapeutics, Inc.
Pliant Therapeutics Inc. is a biopharmaceutical company that finds and makes new treatments for fibrotic diseases.
The company's lead product candidate is bexotegrast (PLN-74809). This is an oral, small molecule, dual-selective inhibitor of αvβ6 and αvβ1 integrins. Bexotegrast is being developed for idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC).
Pliant is also developing PLN-101095, an oral, small molecule, dual-selective inhibitor of αvβ8 and αvβ1 integrins, for the treatment of solid tumors. Additionally, PLN-101325, a monoclonal antibody designed to act as an allosteric agonist of integrin α7β1, is being developed for muscular dystrophies.
Pliant Therapeutics, Inc. (PLRX) Historical Performance
IPO Date
Pliant Therapeutics, Inc. (NASDAQ:PLRX) went public on 03 June, 2020.
Change
Since inception, PLRX has decreased by 87.46%. In the last 5 years, PLRX has fallen from $23.29 to $2.92, a massive -87.46% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $39.33 and a low of $2.92.
52 Week Range
$2.82
$18.0
The current price $2.92 is near the 52-week low, which means that the stock is underbought.
PLRX Stock Price History
Based on PLRX stock's historical price data, this table shows how the stock has performed in the last 5 years. Since 2020, the PLRX stock has fallen from $13.5 - $39.33 to $2.92 - $10.75, which is down -71.29%. Currently, the stock follows downward trend.
Here, we have calculated stock range of PLRX, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2021 | $13.5 - $39.33 | $24.05 | 0.94 | 1 Year Change |
| 2022 | $5.63 - $24.87 | $13.94 | -41.49 | 2 Year Change |
| 2023 | $13.89 - $35.04 | $21.69 | -8.96 | 3 Year Change |
| 2024 | $10.75 - $17.92 | $13.6 | -42.92 | 4 Year Change |
| 2025 | $2.92 - $10.75 | $6.84 | -71.29 | 5 Year Change |
PLRX Price Performance
6-Month Performance
PLRX stock dropped by 73.95% in the last six months.
1-Year Performance
The stock has trended downwards by 80.40% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 58.34%.
According to Pliant Therapeutics, Inc.'s historical data, below graph gives us the exact picture of how the PLRX stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 3 years.
2021
40.58% ↓
2022
43.19% ↑
2023
6.31% ↓
2024
27.28% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Pliant Therapeutics, Inc. (PLRX) Financials & Stock Analysis
Market Capitalization
Pliant Therapeutics, Inc. has a market capitalization of $177.39M, which places PLRX in the micro-cap category.
Fundamental Analysis
EPS: $-0.95 (Q3), $-2.75 (1Y)
EPS increased 3.26% since last quarter, and decreased 6.46% since last year.
Net Income: $-57.76 M (Q3), $-161.34 M (1Y)
Net Income increased 3.42% since last quarter, and increased 30.83% since last year.
Free Cash Flow: $-33.17 M (Q3), $-117.28 M (1Y)
Free Cash Flow decreased N/A since last quarter, and increased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for PLRX stock. These indicators help you understand Pliant Therapeutics, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for PLRX stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $10.72 |
| SMA50 | $12.53 |
| SMA200 | $12.72 |
| RSI | 17.48 |
| Beta | 1.09 |
SMA20 > Current Price
This signals PLRX stock is in short-term bearish momentum.
SMA50 > Current Price
This signals PLRX stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals PLRX stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for PLRX stock is Bearish. Out of all indicators, 3 indicates bullish signals, 6 signals bearish trends and 0 gives neutral trends. The PLRX stock forecast was last updated on 10 February, 2025.
Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $16.89 by the end of 2025, and can reach around $26.28 to $7.31 in 2026. And, the long-term forecast suggests that the stock may further drop to $0.81 - $1.35 in 2028, and $1.03 - $0.97 by 2031. So, the PLRX stock shows a strong upward trend in the next several years.
Short-term PLRX Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $24.39 | 735.25% |
| 2025-04 | $20.18 | 591.07% |
| 2025-05 | $19.27 | 559.91% |
| 2025-06 | $17.04 | 483.54% |
| 2025-07 | $20.18 | 591.07% |
| 2025-08 | $19.12 | 554.77% |
| 2025-09 | $16.30 | 458.2% |
| 2025-10 | $13.83 | 373.61% |
| 2025-11 | $13.08 | 347.93% |
| 2025-12 | $16.89 | 478.4% |
In 2025, the PLRX stock price is expected to fluctuate between $13.08 and $24.39. According to the monthly forecast, the stock could rise to $16.89 by December 2024. If compared to the PLRX's current price, the stock could gain 478.4% by the end of this year.
Long-term PLRX Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $26.28 | $15.67 | $7.31 | 150.33% |
| 2027 | $7.56 | $1.21 | $1.05 | -64.04% |
| 2028 | $0.81 | $1.08 | $1.35 | -53.77% |
| 2029 | $0.90 | $1.44 | $0.97 | -66.78% |
| 2030 | $0.93 | $0.99 | $1.18 | -59.59% |
| 2031 | $1.03 | $1.11 | $0.97 | -66.78% |
| 2032 | $0.92 | $0.85 | $1.03 | -64.73% |
| 2033 | $0.92 | $0.80 | $0.93 | -68.15% |
| 2034 | $1.08 | $1.18 | $1.17 | -59.93% |
| 2035 | $0.86 | $1.01 | $1.35 | -53.77% |
| 2036 | $0.92 | $1.10 | $0.88 | -69.86% |
| 2037 | $0.85 | $1.00 | $0.71 | -75.69% |
| 2038 | $1.16 | $0.77 | $0.98 | -66.44% |
| 2039 | $0.79 | $1.13 | $0.68 | -76.71% |
| 2040 | $0.99 | $1.08 | $1.23 | -57.88% |
| 2041 | $0.58 | $1.25 | $1.06 | -63.7% |
| 2042 | $0.96 | $1.04 | $0.67 | -77.06% |
| 2043 | $0.91 | $1.04 | $1.11 | -61.99% |
| 2044 | $0.70 | $0.91 | $1.20 | -58.91% |
| 2045 | $0.53 | $1.23 | $0.87 | -70.21% |
| 2046 | $0.83 | $1.00 | $1.17 | -59.93% |
| 2047 | $0.86 | $1.24 | $1.06 | -63.7% |
| 2048 | $1.16 | $1.07 | $1.06 | -63.7% |
| 2049 | $0.94 | $0.83 | $0.55 | -81.17% |
| 2050 | $0.82 | $1.08 | $1.33 | -54.45% |
| 2051 | $0.88 | $1.01 | $0.88 | -69.86% |
Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction & Forecast 2025
At the start of 2025, the PLRX stock was at $10.75. Today, it is trading at $2.92, which is -72.84% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $16.89 by December 2025 with a 478.40% change.
Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the PLRX stock. During this period, the PLRX's price is forecasted to shift from $26.28 to $1.18, which is -95.51% loss.
In 2026, the stock would possibly open at $26.28, descends to $15.67 by mid-year, and wraps up at $7.31, reflecting a 150.48% increase from today's price. Further moving to 2030, the stock can kick off the year at $0.93, drop to $0.99 by mid-year, and finish at $1.18, which is -59.69% change from current price.
Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.03 to $1.23, which is up -66.85%
In 2031, we can expect PLRX to fluctuate between $0.97 and $1.03, a shift indicating a -66.85% loss by year-end compared to current price. And Until 2040, PLRX can likely vary from $0.99 to $1.23. By the end of 2040, the stock could record a -57.86% fall from today's stock price.
Pliant Therapeutics, Inc. (PLRX) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the PLRX stock can see an an upturn from $0.58 to $1.33 in this period. In 2041, the stock can experience a high of $1.25 by mid-year, closing the year at $1.06. This results in a -57.31% decrease from today.
Moving towards the end of 2050, PLRX is projected to open the year at $0.82. The stock may peak to $1.08 during mid-year and finish the year at $1.33. Compared to the stock's current price, this translates to an overall loss of -54.49% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
PLRX Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| ATAI | Atai Life Sciences N.V. | - | $2.34 | 50.97% ▲ | $34.65 ▲ |
| TNXP | Tonix Pharmaceuticals Holding Corp. | - | $0.38 | 16.09% ▲ | $161.03 ▲ |
| OCGN | Ocugen, Inc. | - | $0.78 | -3.11% ▼ | $275.15 ▲ |
| MRNA | Moderna, Inc. | - | $42.25 | 1.61% ▲ | $304.87 ▲ |
| IPA | ImmunoPrecise Antibodies Ltd. | - | $0.48 | 2.92% ▲ | $108.94 ▲ |
Last updated Feb 10 at 3:01 PM
PLRX : Buy, Sell Or Hold?
Analyst Ratings
Based on 10 analysts, 3 rated as a strong buy, 3 recommended a buy, 4 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for PLRX stock is Buy.
Expert Analysis
According to PLRX short-term and long-term forecast, Pliant Therapeutics, Inc. shares are projected to go down by 54.45%, and reach a value of $1.33 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, PLRX has recorded 7/30 green days, which reflects a 35.0% positivity rate with a price volatility of 0.14%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that PLRX stock is undervalued. So, Based on PLRX prediction and analysis, it may be the best time to sell PLRX stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "PLRX” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.